ArticleCureus2024
Markedly T2-Hypointense Clival Plasmacytoma With Light Chain Deposition Disease: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmacytomas are rare monoclonal neoplastic plasma cell proliferations in soft tissue or bone, with clival plasmacytomas being extremely rare and occasionally presenting with light chain deposition disease (LCDD). While imaging findings for clival plasmacytomas have shown variable T2 signal characteristics, complete T2 signal loss has not been previously reported. We present a case of a 61-year-old female found to have a 1.9 cm expansile lytic lesion in the clivus on CT. MRI revealed intermediate T1 signal and near-complete T2 signal loss. Histopathology demonstrated kappa-restricted plasma cells with extracellular light chain deposition, while bone marrow biopsy showed 5-10% plasma cells without evidence of multiple myeloma. The patient was diagnosed with a solitary plasmacytoma of the clivus with associated LCDD and underwent endoscopic resection and radiotherapy, showing a favorable initial response at a seven-month follow-up. This case highlights the importance of considering plasmacytoma with associated LCDD for marked T2 hypointense, enhancing skull base lesions. The combination of plasmacytoma and LCDD may explain the unusual imaging characteristics, underscoring the need for comprehensive diagnostic approaches in patients presenting with unusually hypointense clival lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.